Lyell Immunopharma, Inc. has announced plans to accelerate the development of IMPT-314, a dual-targeting CD19/CD20 CAR T-cell therapy for aggressive large B-cell lymphoma, with pivotal trials expected ...
Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes. In recent years, CAR-T cell therapies have become ...
A research team at the University of Cologne's Center for Molecular Medicine Cologne (CMMC) has discovered that the protein ...
Translocations are chromosomal “cut and paste” errors that drive many lymphomas, a type of blood cancer and the sixth most common form of cancer overall. This includes mantle cell lymphoma, a rare but ...
For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an "identity crisis." Normally, a B cell ...
For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells ...
Urban China is expected to lead globally in diagnosed PCNSL cases in 2024 and 2029. Current treatment relies on off-label use and BTK inhibitors, but there's a significant unmet need driving ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more ...
Weill Cornell Medicine scientists have identified Hodgkin lymphoma cells as immune cells halted midway between B cells and plasma cells, reframing the disease as one of failed development. The ...
New population studies suggest that tattoos may be associated with a higher risk for lymphoma and skin cancer, although ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results